Search results for "Myocardial infarction"
Kidney failure, CV events lower with canagliflozin than placebo, industry study finds
The trial was stopped early after an interim safety analysis found significantly better renal and cardiovascular outcomes among type 2 diabetes patients randomized to canagliflozin than those assigned to placebo.
https://immattersacp.org/weekly/archives/2019/04/23/2.htm
23 Apr 2019
Weighing benefits, harms of cannabis
Marijuana use has risen, so internists need to understand its real risks as well as its potential clinical uses, such as for chronic pain, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity symptoms.
https://immattersacp.org/archives/2019/04/weighing-benefits-harms-of-cannabis.htm
1 Apr 2019
More options available for psoriatic arthritis
Internists are the first doctors patients see for joint pain, which means they can make a big difference in preventing the progression of joint diseases such as psoriatic arthritis.
https://immattersacp.org/archives/2019/04/more-options-available-for-psoriatic-arthritis.htm
1 Apr 2019
MKSAP Quiz: Routine visit for HIV
A 44-year-old man is evaluated in the office during a routine visit. Medical history is significant for HIV diagnosed at age 25 years, hypertension, and hyperlipidemia. He is a current smoker. Following a physical exam, cardiac exam, and lab tests, what risk factors will result in underestimation of the risk for atherosclerotic cardiovascular disease in this patient?
https://immattersacp.org/weekly/archives/2019/03/19/3.htm
19 Mar 2019
Warfarin-aspirin therapy associated with increased bleeding compared with warfarin only
Patients with atrial fibrillation or venous thromboembolism who received aspirin without a clear therapeutic indication in addition to warfarin had higher rates of bleeding and similar rates of thrombosis.
https://immattersacp.org/weekly/archives/2019/03/12/2.htm
12 Mar 2019
Aspirin associated with fewer CV events, more major bleeding in healthy patients, review finds
When weighing the risks and benefits of aspirin for primary cardiovascular (CV) prevention in individual patients, clinicians must also consider other interventions that may lower risk, an accompanying editorial said.
https://immattersacp.org/weekly/archives/2019/01/29/1.htm
29 Jan 2019
A defense of proton-pump inhibitors
Data on their risks may seem persuasive, but one expert is not convinced.
https://immattersacp.org/archives/2019/01/a-defense-of-proton-pump-inhibitors.htm
1 Jan 2019
MKSAP Quiz: Routine office visit for patient with HIV
A 44-year-old man is evaluated in the office during a routine visit. Medical history is significant for HIV diagnosed at age 25 years, hypertension, and hyperlipidemia. He is a current smoker. Following a physical exam, lab tests, and electrocardiogram, what factors will result in underestimation of the risk for atherosclerotic cardiovascular disease in this patient?
https://immattersacp.org/weekly/archives/2018/12/18/3.htm
18 Dec 2018
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://immattersacp.org/weekly/archives/2018/12/04/2.htm
4 Dec 2018
MKSAP Quiz: Shortness of breath following hospital discharge
A 52-year-old woman is evaluated during a follow-up visit following a small non–ST-elevation myocardial infarction treated with drug-eluting stent. Since discharge, she has had shortness of breath. Following a physical exam and chest radiograph, what is the most likely cause of this patient's dyspnea?
https://immattersacp.org/weekly/archives/2018/10/30/3.htm
30 Oct 2018